Skip to main content

Desvenlafaxine News

FDA Approves Khedezla for Major Depressive Disorder

July 10, 2013 – The United States Food and Drug Administration today approved Khedezla (desvenlafaxine) extended-release tablets for the treatment of major depressive disorder. Khedezla contains the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Weight Loss (Obesity / Overweight), Major Depressive Disorder, Attention-Deficit Hyperactivity Disorder (ADHD), Anxiety, Bipolar Disorder, Depression, Fibromyalgia, Hot Flashes, Narcolepsy, Neuralgia, Panic Disorder, Post Traumatic Stress Disorder, Postmenopausal Symptoms

Related drug support groups

Pristiq

Desvenlafaxine patient information at Drugs.com